Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...

New York men are absolute pros at making you feel like the hottest woman alive. Just don’t expect them to stick around.

Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival ...

High-protein diets have become mainstream. On social media, food and fitness influencers recommend protein. Celebrities have ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

Stacker surveyed Billboard's Hot 100 chart in 1975 to highlight the top 50 songs turning 50 in 2025. See which hits made the ...

Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) ...

The track, produced by Blake Slatkin and longtime Lizzo collaborator Ricky Reed, is a placid Strokes-y thumper whose riff periodically breaks free from its cage during a chorus that kicks the ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

With Hims & Hers' main source of growth set to be extinguished, Citi analysts said its full-year guidance appeared ...

Real Housewives of New Jersey star Dolores Catania was among the first crop of celebrities who openly and unabashedly admitted to using Ozempic or a similar drug to lose weight. Now, after two ...

The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk’s NOVO.B0.51%increase; green up pointing triangle weight-loss medications Wegovy and Ozempic has been resolved ...